Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
doi:10.1007/s00018-007-7218-4 Abeti R, Duchen MR
doi: 10.1016/j.jds.2024.09.021 180 RuanJWeiXLiSYeZHuLZhuangRet al
Results for Phase II Clinical Trial of LCL161, a SMAC Mimetic, in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (post-PV MF) or Post-Essential Thrombocytosis Myelofibrosis (post-ET MF)
Ganesan S, Kappel C, Gou P, Mlayah B, Chiquet M, Hontonnou F, Zassadowski F, Cassinat B, Pla M, Sarda-Mantel L, Hosten B, Konopleva M, Andreeff M , Ades L, Setterblad N, Krief P, Omidvar N, Chomienne C, Fenaux P, Padua RA
US$ 29.85
US$ 24.82
US$ 25.40
